Total Payments
$15,843
2024 Payments
$2,491
Companies
38
Transactions
1,025
Medicare Patients
5,925
Medicare Billing
$609,109
Payment Breakdown by Category
Food & Beverage$15,524 (98.0%)
Education$218.60 (1.4%)
Gifts$100.00 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,524 | 1,020 | 98.0% |
| Education | $218.60 | 4 | 1.4% |
| Gift | $100.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,736 | 292 | $0 (2024) |
| ABBVIE INC. | $3,499 | 190 | $0 (2024) |
| Janssen Biotech, Inc. | $2,891 | 192 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $794.39 | 49 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $474.10 | 24 | $0 (2017) |
| Allergan Inc. | $468.21 | 42 | $0 (2019) |
| INTERCEPT PHARMACEUTICALS, INC. | $394.32 | 26 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $390.71 | 24 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $369.18 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $326.24 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,491 | 124 | ABBVIE INC. ($1,199) |
| 2023 | $2,460 | 139 | ABBVIE INC. ($780.67) |
| 2022 | $2,577 | 161 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($661.25) |
| 2021 | $2,380 | 170 | Janssen Biotech, Inc. ($692.86) |
| 2020 | $661.06 | 52 | Janssen Biotech, Inc. ($211.31) |
| 2019 | $1,723 | 128 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($693.17) |
| 2018 | $1,967 | 150 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($791.37) |
| 2017 | $1,584 | 101 | Valeant Pharmaceuticals North America LLC ($474.10) |
All Payment Transactions
1,025 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $23.81 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $84.00 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,702 | 3,603 | $618,833 | $168,907 |
| 2022 | 18 | 1,411 | 4,595 | $560,911 | $150,464 |
| 2021 | 19 | 1,377 | 3,852 | $531,102 | $150,589 |
| 2020 | 19 | 1,435 | 5,455 | $537,720 | $139,150 |
Total Patients
5,925
Total Services
17,505
Medicare Billing
$609,109
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 324 | 374 | $47,498 | $31,269 | 65.8% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2023 | 124 | 124 | $113,192 | $24,448 | 21.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 129 | 130 | $108,806 | $18,486 | 17.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 194 | 199 | $83,410 | $12,038 | 14.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $13,580 | $7,767 | 57.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 60 | 62 | $30,814 | $6,955 | 22.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 39 | 39 | $23,727 | $6,608 | 27.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 51 | 51 | $29,886 | $6,321 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $10,541 | $5,887 | 55.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 58 | 63 | $29,072 | $5,850 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 97 | $9,215 | $5,672 | 61.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 109 | 216 | $14,472 | $5,209 | 36.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 62 | 101 | $9,292 | $4,920 | 53.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 19 | 19 | $8,322 | $4,323 | 52.0% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 54 | 68 | $7,616 | $4,074 | 53.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 56 | $4,872 | $3,183 | 65.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 40 | $30,666 | $3,166 | 10.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $16,808 | $3,115 | 18.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 35 | 38 | $6,650 | $2,897 | 43.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 15 | $9,000 | $2,545 | 28.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $4,636 | $2,472 | 53.3% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 14 | 14 | $3,500 | $971.75 | 27.8% |
| 45331 | Biopsy of lower large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $2,340 | $538.32 | 23.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 22 | 1,669 | $917.95 | $189.20 | 20.6% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 175 | 175 | $158,550 | $35,394 | 22.3% |
About Dr. Dino Ferrante, MD
Dr. Dino Ferrante, MD is a Gastroenterology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104815471.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dino Ferrante, MD has received a total of $15,843 in payments from pharmaceutical and medical device companies, with $2,491 received in 2024. These payments were reported across 1,025 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($15,524).
As a Medicare-enrolled provider, Ferrante has provided services to 5,925 Medicare beneficiaries, totaling 17,505 services with total Medicare billing of $609,109. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Huntsville, AL
- Active Since 10/19/2005
- Last Updated 04/10/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104815471
Products in Payments
- STELARA (Biological) $2,780
- XIFAXAN (Drug) $2,520
- LINZESS (Drug) $981.63
- RINVOQ (Biological) $824.67
- SKYRIZI (Biological) $777.15
- DUPIXENT (Biological) $574.65
- TRULANCE (Drug) $517.79
- ENTYVIO (Biological) $418.06
- RELISTOR (Drug) $397.64
- OCALIVA (Drug) $382.39
- VIBERZI (Drug) $375.89
- APRISO (Drug) $362.60
- Linzess (Drug) $320.09
- Humira (Biological) $309.07
- HUMIRA (Biological) $298.14
- DIFICID (Drug) $295.19
- ZENPEP (Drug) $228.81
- CLENPIQ (Drug) $226.46
- MOTEGRITY (Drug) $178.81
- SUCRAID (Drug) $168.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Huntsville
Michael Dohrenwend, Md, MD
Gastroenterology — Payments: $48,133
Gastroenterology $48,133
John-Paul Voelkel, M.d, M.D
Gastroenterology — Payments: $17,351
Gastroenterology $17,351
Meredith Roath, M.d, M.D
Gastroenterology — Payments: $16,777
Gastroenterology $16,777
Charles Billings, Md, MD
Gastroenterology — Payments: $16,031
Gastroenterology $16,031
Mark Moglowsky, Md, MD
Gastroenterology — Payments: $12,186
Gastroenterology $12,186
Suresh Karne, Md Phd, MD PHD
Gastroenterology — Payments: $11,520
Gastroenterology $11,520